31st Oct 2012 17:38
Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: UNITED DRUG PUBLIC LIMITED COMPANY
2. Reason for the notification (please tick the appropriate box or boxes):
[ X] an acquisition or disposal of voting rights
[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
[ ] an event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation:
AVIVA PLC AND ITS SUBSIDIARIES
4. Full name of shareholder(s) (if different from 3.):
REGISTERED HOLDER:
BNY Norwich Union Nominees Limited 493,849*
Chase (GA Group) Nominees Ltd 5,704,142*
Chase Nominees Limited 600,522*
CUIM Nominee Limited 133,004*
*denotes direct interest
5. Date of the transaction and date on which the threshold is crossed or reached:
26 OCTOBER 2012
6. Date on which issuer notified;
31 OCTOBER 2012
7. Threshold(s) that is/are crossed or reached:
3% TO
8. Notified details:
A) Voting rights attached to shares | |||||||
Class/type of shares (if possible using the ISIN CODE) | Situation previous to the Triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of Shares | Number of Voting rights | Number of shares | Number of voting rights | % of voting rights | |||
| Direct | Direct | Indirect | Direct | Indirect | |||
IE0033024807 | 7,360,294 | 7,360,294 | 6,931,517 | 6,931,517 | Below Threshold | 2.89% | Below Threshold |
B) Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
SUBTOTAL B (in relation to all expiration dates) | ||||
Total (A+B) | number of voting rights | % of voting rights |
6,931,517 | 239,544,133 | 2.89% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instrumentsare effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
·; Aviva plc (Parent Company)
·; Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
·; Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
·; Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
10. In case of proxy voting:[name of the proxy holder] will cease to hold [number] voting rights as of [date].
11. Additional information:
Figures are based on a total number of voting rights of 239,544,133, as per the Company's Total Voting Rights Announcement of 1 October 2012.
Annex to the standard form TR-1
a) Identity of the person or legal entity subject to the notification obligation:
Full name (including legal form for legal entities) | UNITED DRUG PUBLIC LIMITED COMPANY................................ |
Contact address (registered office for legal entities) | UNITED DRUG HOUSE MAGNA DRIVE MAGNA BUSINESS PARK CITYWEST ROAD DUBLIN 24 ..................................................................... ..................................................................... |
Phone number | .................................................................... |
Other useful information (at least legal representative for legal persons) | ……………………………………………. |
b) Identity of the notifier, if applicable:
Full name | DIANE THIRKETTLE GLOBAL REPORTING UNIT AVIVA PLC SURREY STREET NORWICH NR1 3DR .................................................................... |
Contact address | ..................................................................... ..................................................................... |
Phone number | 00 44 1603 687803 .................................................................... |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
c) Additional information
Related Shares:
UDG.L